About Contact Us Careers
Sign In

Cell Counting Market - Top Companies and Manufacturers

  • Report ID: 3546
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Companies Dominating the Cell Counting Landscape

    • Merck KgaA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • Perkin Elmer Inc.
    • Olympus Corporation
    • Tecan Trading AG
    • Abbott Laboratories
    • General Electric Company
    • Boule Diagnostics AB
    • Becton, Dickinson, and Company
    • Sysmex Corporation
Browse Key Market Insights with Data Illustration:

In the News

  • Becton, Dickinson, and Company introduced BD FACSymphony A1 Cell Analyzer, which provides labs of all sizes access to powerful flow cytometry capabilities. Further, it is a fluorescence-activated cell analyzer that provides cutting-edge research capabilities in a small-footprint design, making it easier for more labs to obtain instruments for difficult scientific research.

  • Sysmex Corporation, a leading diagnostic solutions provider, received FDA approval for residual white blood cell counts, which will be added to its XN-10 Automated Hematology Analyzer with Blood Bank mode. Further, this analyzer offers residual white blood cell counts, red blood cell (RBC), and platelet (PLT) component testing in a single sample aspiration.


Author Credits:  Radhika Pawar


  • Report ID: 3546
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell counting is evaluated at USD 11.09 billion.

The cell counting market size was valued at USD 10.09 billion in 2024 and is anticipated to exceed USD 46.16 billion by the end of 2037, registering over 12.3% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of infectious diseases, and surging incidences of target diseases such as HIV will boost the market growth.

Asia Pacific is poised to dominate majority industry share by 2037, attributed to increasing cases of cancer.

The major players in the market include Merck KgaA, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Olympus Corporation, Tecan Trading AG, Abbott Laboratories, General Electric Company, Boule Diagnostics AB, Becton, Dickinson, and Company, Sysmex Corporation.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample